About Mosanna
Mosanna Therapeutics is a pre-clinical biotech company developing a medicinal nasal spray for obstructive sleep apnea. The company aims to expand the range of treatment options for OSA and provide therapy in a familiar, user-friendly modality.
Established:
2022
Leaders:
Ben Machielse | Chairman
Jonathan Talbot, PhD | Founder & CEO
Work for Mosanna
View Open Positions